Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease

Aim: Adverse limb events after endovascular therapy (EVT) are a major concern. This study aimed to investigate the relationship between serum malondialdehyde-modified low-density lipoprotein (MDA-LDL) level, a potentially potent indicator of atherosclerosis, and clinical outcomes after EVT in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoi, Masashi, Ito, Tsuyoshi, Kawada, Yu, Mizoguchi, Tatsuya, Yamamoto, Junki, Mori, Kento, Nakasuka, Kosuke, Kikuchi, Shohei, Fujita, Hiroshi, Kitada, Shuichi, Goto, Toshihiko, Seo, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627766/
https://www.ncbi.nlm.nih.gov/pubmed/36889737
http://dx.doi.org/10.5551/jat.64091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627766/
https://www.ncbi.nlm.nih.gov/pubmed/36889737
http://dx.doi.org/10.5551/jat.64091

Ejemplares similares